Urology Times presents Case-Based Peer Perspectives. In each video, expert physicians provide insight on managing urology-based patient cases that highlight the use of novel agents in clinical practice.
A 67-Year-Old-Man with Metastatic Prostate CancerJanuary 18th 2023
Stephen J. Freedland, MD, presents the case of a 67-year-old man with metastatic castration-resistant prostate cancer (mCRPC) and discusses the available treatment options and data that influence treatment selection for patients with the disease.
A 60-Year-Old Woman With Muscle-Invasive Bladder Cancer and a 77-Year-Old Man With Muscle-Invasive Bladder CancerDecember 23rd 2022
Karim Chamie, MD, presents 2 cases of patients with muscle-invasive bladder cancer (MIBC), reviews the chosen treatment regimens, and details which clinical and non-clinical factors influence treatment recommendations.
A 66-Year-Old-Man with Metastatic Prostate CancerAugust 9th 2022
Jason Hafron, MD, presents the profile of a 66-year-old man with metastatic castration-sensitive prostate cancer, details the available treatment regimens, and discusses clinical trial data on the use of androgen deprivation therapy combined with a treatment-intensifying agent.
A 64-Year-Old-Man with Metastatic Prostate CancerMay 23rd 2022
Neal Shore, MD, presents the case of a 64-year-old man with metastatic prostate cancer, reviews the potential treatment options, including PARP inhibitors, and highlights the importance of genetic testing when selecting treatment regimens.